Overview

MK0524 Asthma POC Study (0524-008)(COMPLETED)

Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to demonstrate the benefit of MK0524 compared to placebo in patients with chronic asthma.
Phase:
Phase 2
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Montelukast